Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Adial, Celltype, Cirna, Congruence, Corstasis, Curie.Bio, Esperion, Forendos, Hepion, Kdventures, Molteni, Ono, Organon, Secarna, Senhwa, Sinopia.
Clinical updates for biopharma and med tech, including data readouts and publications: Bioaffinity, Biocardia, Chiesi, Cour, Delcath, Ensysce, Quell, Snipr, Theravance.
Biopharma and med-tech companies raising money in public or private financings, including: Antiverse, Beken, Informuta, Maia, Modular, Poplar, Prolium, Xsensio.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbott, Agios, Ascendis, Biomarin, Innocare, Innovent, Intellia, Merck, Novo Nordisk, Protagonist, Sanofi, Scibase, Takeda, Uniqure.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Bioatla, Blueprint, Celyn, Cullgen, Deephealth, Disc, Gyre, Kairos, Medimaps, Opgen, Pulmatrix, Radiobiotics.
Clinical updates for biopharma and med tech, including data readouts and publications: Aardvark, Abbvie, Bayer, Bioxytran, Celldex, Cogent, DBV, Longbio, Merck, Opus, Rhythm, Roche, Septerna, United, Upstream.
Biopharma and med-tech companies raising money in public or private financings, including: Beone, Defence, Edison, Jazz, Royalty, Sharp, Telo Genomics, Zymeworks.
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Asieris, Cstone, Dr. Reddy’s, Optellum, Photocure.